The longevity signal for brewed tea in the cohort literature is modest, replicated, and the size of effect a cautious doctor would actually believe. The same plant, ground up and concentrated into capsules, has put more than a hundred people in the hepatology literature with acute liver injury. The same plant again, blended with condensed milk and tapioca pearls and sold for ten dollars a cup, can pour in the sugar load of a Coke before you stir it. One leaf. Three businesses. Only one of them is selling you what the studies measured.
That is the through-line of a new review out of the Tea Research Institute of the Chinese Academy of Agricultural Sciences with senior authorship by Chung S. Yang of Rutgers, one of the most-cited green-tea-polyphenol researchers in the field. The institutional alignment is worth naming up front: a Chinese government tea-research institute writing a favorable review of tea is something to weigh as you read. But the underlying epidemiology the review draws from is independent of them, and the numbers are not extraordinary claims. They are small, plausible, and reproducible.
The cleanest signal comes from a meta-analysis of 38 prospective cohorts covering nearly 2 million participants. The highest tea drinkers in those studies died of any cause at roughly 10 percent lower rates than the lowest (pooled effect 0.90, 95% CI 0.86 to 0.95), with cardiovascular mortality falling about 14 percent (0.86, 0.79 to 0.94). Cancer mortality drifted in the same direction but the confidence interval crossed 1, so I would not lean on the cancer claim. The sweet spot sits around 1.5 to 2 cups a day, and the curve flattens after that. You do not get bonus years for drinking eight cups.
Now the mechanism, because this is where it actually gets interesting. Tea leaves are stuffed with catechins, and the most studied is epigallocatechin-3-gallate, EGCG. Brew a cup at home and you are getting somewhere in the range of 50 to 150 mg of EGCG in solution, sipped slowly over twenty minutes, absorbed in the gut alongside whatever else you ate, much of it metabolized before it ever reaches your liver. Day after day, decade after decade, that gentle drip seems to nudge the vascular and metabolic dials in a useful direction. Nothing about any single cup is dramatic; the chronic exposure is the whole point.
This is where the supplement industry takes the same molecule and breaks it.
Pull EGCG out of the leaf, concentrate it many-fold, dump several hundred milligrams into a single capsule, and tell people to take it on an empty stomach to boost absorption. You have changed the pharmacology entirely. The NIH’s LiverTox database catalogues more than 100 published case reports of clinically apparent liver injury attributed to green-tea-extract supplements, at doses ranging from roughly 140 to 1,000 mg of EGCG a day. The European Food Safety Authority concluded in 2018 that 800 mg of EGCG daily from supplements can drive significant elevations in liver enzymes, and the EU followed up by capping the EGCG content allowed in food supplements. The US Pharmacopeia, which sets voluntary supplement-quality standards, reviewed the same evidence and added a cautionary label requirement to its green-tea-extract monograph: do not take on an empty stomach, do not use if you have a liver problem, discontinue if you develop jaundice.
The catch is that the USP monograph is voluntary, and US supplement law under DSHEA does not require pre-market safety review or anything like the EU restriction. The same EGCG-extract products that European regulators now cap sit on US shelves with weight-loss and metabolism-support marketing, often without the cautionary label USP recommends. That gap is structural, and it sits exactly where you would expect it given how supplement enforcement actually works in this country.
None of which is to say EGCG is dangerous. The gentle daily exposure your grandmother got from a teapot is a fundamentally different biological event than what happens when a private-label supplement company concentrates the same chemistry into a pill an Instagram influencer is paid to push. The molecule is the same. The dose, the matrix, the absorption, the cumulative liver hit are not.
The bottled and bubble-tea story is uglier in a different way. A typical 16-ounce full-sugar boba tea with milk and tapioca carries roughly 38 grams of added sugar, about what is in a 12-ounce can of Coca-Cola, and specialty drinks push well past 50. The tapioca pearls are starch coated in syrup so they do not stick together. The condensed-milk base is another 20 to 30 grams of sugar. The catechin content of the underlying tea is genuine, but you are pairing it with a sugar load that erases the metabolic benefit the cohort data was measuring. The wellness branding on boba is a clean inversion of the actual nutrition.
Even the plain brewed version has its supply-chain footnotes. A McGill team brewing single plastic teabags at 95°C measured billions of microplastic and nanoplastic particles released into the cup, with their headline figure of 11.6 billion microplastic particles per teabag later contested by German regulators who think the count is several orders of magnitude too high. The qualitative finding that hot water and plastic mesh do not mix is not in dispute, and it is enough reason to put the pyramid-bag products directly in the trash. Loose-leaf in glass or stainless steel sidesteps the whole question for the cost of a strainer.
What I actually make of all of this, after a few hours digging through the data: drink the leaf. Two cups of plain green or black tea a day, brewed loose, no syrup, no plastic, and you are buying yourself the modest longevity nudge the cohort data is measuring at the price of a kettle. Skip the EGCG capsules entirely, because the only documented harms in this whole story sit there. Skip the bottled iced teas pretending to be functional beverages. Treat boba as dessert, because that is what it is.
The longevity story for tea is not a miracle. It is a small, consistent benefit from a cheap habit. The supplement industry and the bottled-drink industry have spent the last decade extracting the brand value of that habit while gutting the parts that made it work. The brewed leaf still wins. The packaging is the problem.
Sources
- ScienceDaily coverage of the Yang et al. 2025 tea review in Beverage Plant Research
- Meta-analysis of tea consumption and all-cause and cardiovascular mortality, 38 cohorts, ~2 million participants (Epidemiology and Health)
- NIH LiverTox: Green tea extract hepatotoxicity, dose ranges and case-report counts
- EFSA 2018 scientific opinion on the safety of green tea catechins, identifying the 800 mg EGCG/day threshold
- Food Safety Magazine: EU restrictions on green-tea-extract supplements over liver-damage risk
- Oikonomopoulou et al., United States Pharmacopeia comprehensive review of the hepatotoxicity of green tea extracts (Toxicology Reports, 2020)
- Hernandez et al., Plastic Teabags Release Billions of Microparticles and Nanoparticles into Tea (Environmental Science & Technology, 2019)